Not Signed In - Mylan Announces Tentative Approval For Venlafaxine Hydrochloride Tablets
Tue, 15 Aug 2006 07:00 AM EST
... Mylan Laboratories Inc.(NYSE: MYL) announced that the U.S. Food and Drug Administration hasgranted tentative approval for Mylan Pharmaceuticals Inc.'s Abbreviated NewDrug Application for Venlafaxine Hydrochloride Tablets 25 mg (base), 37.5mg (base), 50 mg (base), 75 mg (base) and 100 mg (base). Venlafaxine HCl Tablets are indicated for the treatment of majordepressive disorder. [click link for full article] ...
Related Topics
- Carbinoxamine and Pseudoephedrine Tablets
- Vaccine Testing & Approval
- Venlafaxine
- Tetracycline Tablets or Capsules
- Guaifenesin and Hydrocodone
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Cyanocobalamin Tablets
- Chlorpheniramine, Pseudoephedrine and Hydrocodone Tablets
- Guaifenesin and Dextromethorphan
- Thiabendazole Tablets
- Haloperidol Tablets
- Neostigmine Tablets
- Carbetapentane, Phenylephrine, and Pyrilamine
- Ergoloid Mesylates Sublingual Tablets
- Nystatin Tablets
- Desmopressin Tablets
- Isosorbide Dinitrate, Tablets or Extended-Release Tablets or Capsules
- Tarceva
- Gatifloxacin tablets
- Fenofibrate Tablets
email this page
print this page
bookmark this page
feedback on this page
